Key Takeaways
- Oil prices surged, with WTI approaching $64 a barrel and Brent exceeding $67, driven by escalating tensions over Russian crude and diesel supplies and calls for NATO action.
- The US FDA declined to approve Scholar Rock's (SRRK) muscle weakness drug, apitegromab, due to manufacturing issues at a third-party facility, causing a premarket share drop of 15%.
- California Attorney General Rob Bonta is reviewing the legality of the Trump administration's $100,000 H-1B visa application fee, citing potential adverse impacts on state businesses and innovation.
- Japanese government bond markets saw mixed movements, with the 10-year JGB yield falling 1 basis point to 1.645% while futures rose.
Global Markets Navigate Geopolitical Tensions and Regulatory Hurdles
Global financial markets are reacting to a confluence of geopolitical developments, key regulatory decisions, and shifts in bond markets. Oil prices have seen a significant surge, while a major pharmaceutical company faces a setback, and a controversial immigration policy draws legal scrutiny.
Oil Prices Surge Amid Russian Supply Concerns
Oil prices experienced a notable surge, pushing West Texas Intermediate (WTI) crude towards $64 a barrel and Brent crude above $67 a barrel. This increase is primarily attributed to rising tensions over Russian crude and diesel supplies, exacerbated by recent Ukrainian drone attacks on Russian refineries. Russia is reportedly considering restrictions on diesel exports in response to these attacks.
Further contributing to the upward pressure, former President Trump's calls for NATO action and threats of tariffs on India for its purchases of Russian oil have heightened supply concerns. Data indicating a fall in US crude inventories also supported the price rally.
Scholar Rock's Drug Approval Halted by FDA Over Manufacturing Issues
Scholar Rock (SRRK) announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its Biologics License Application (BLA) for apitegromab, a drug intended to treat spinal muscular atrophy (SMA). The FDA's decision was not related to the drug's safety or efficacy but stemmed from observations identified during a routine inspection of Catalent Indiana LLC, a third-party fill-finish facility acquired by Novo Nordisk (NVO) in December 2024.
Following the news, shares of Scholar Rock (SRRK) fell significantly, dropping 15% in premarket trading to $27.53. The company stated its intention to resubmit the application once the manufacturing issues at the Catalent facility are successfully resolved.
California Attorney General Reviews Legality of $100,000 H-1B Visa Fee
California Attorney General Rob Bonta is actively reviewing the legality of the Trump administration's recently imposed $100,000 application fee for H-1B visas. Bonta expressed concerns that the measure creates "uncertainty and unpredictability" for businesses within California and could have an "adverse impact" on the state's innovation and economic landscape.
The abrupt decision to implement this substantial fee has caused widespread confusion and apprehension among employers, students, and skilled workers both in the United States and abroad. The policy is expected to particularly affect India's information technology sector, which heavily relies on the H-1B program for skilled talent.
Mixed Movements in Japanese Government Bond Market
The Japanese government bond (JGB) market displayed mixed movements in early trading. The 10-year JGB yield saw a slight decrease of 1 basis point, settling at 1.645%. Concurrently, benchmark 10-year JGB futures experienced a rise of 0.18 point. These movements come amidst ongoing discussions around the Bank of Japan's policy shifts and the country's fiscal health, which continue to influence investor sentiment in the bond market.
Typhoon Ragasa Causes Fatal Flooding in Taiwan
In a tragic natural disaster, 14 people have been reported dead in Hualien, eastern Taiwan, after a barrier lake overflowed during Super Typhoon Ragasa. The incident occurred when a barrier lake, formed by earlier heavy rains and landslides, burst its banks, sending a wall of water into a town.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.